Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.8100
+0.0133 (1.67%)
Jun 10, 2026, 12:38 PM EDT - Market open

MTNB Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
54347109218
Market Cap Growth
26.56%44.70%-94.48%-56.76%-50.27%-19.74%
Enterprise Value
3.890.41-2.5636.1183.42172.95
Last Close Price
0.810.590.5110.8125.0050.50
PS Ratio
---42.8634.086619.16
PB Ratio
1.690.780.342.442.974.16
P/TBV Ratio
1.560.660.332.442.964.04
EV/Sales Ratio
---32.9526.175241.00
EV/EBITDA Ratio
--0.11---
EV/EBIT Ratio
--0.10---
EV/FCF Ratio
--0.16---
Debt / Equity Ratio
0.160.140.280.150.100.08
Net Debt / Equity Ratio
-0.40-0.55-0.58-0.53-0.67-0.86
Net Debt / EBITDA Ratio
0.180.410.190.451.041.88
Net Debt / FCF Ratio
0.180.380.280.661.232.90
Asset Turnover
-000.030.060.00
Quick Ratio
1.132.732.735.256.7111.41
Current Ratio
1.322.793.015.938.0611.73
Return on Equity (ROE)
-270.25%-166.59%-180.74%-82.11%-47.11%-40.07%
Return on Assets (ROA)
-106.25%-70.13%-129.88%-67.98%-46.33%-37.39%
Return on Invested Capital (ROIC)
-182.70%-151.12%-314.18%-210.68%-211.69%-238.66%
Return on Capital Employed (ROCE)
-146.42%-88.55%-151.54%-75.43%-50.44%-39.77%
Buyback Yield / Dilution
-14.91%-12.50%-11.98%-0.21%-3.16%-6.75%
Total Shareholder Return
-14.91%-12.50%-11.98%-0.21%-3.16%-6.75%
SEC Filings: 10-K · 10-Q